Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic.

Céline CailletChanvilay SichanhGaëtan AssematMyriam Malet-MartinoAgnès SommetHaleh BagheriNoudy SengxeuNiphonh MongkhonmathMayfong MayxayLamphone SyhakhangMaryse Lapeyre-MestrePaul N NewtonAnne Roussin

Published in: Drug safety (2018)

According to the results of this study, there is a need to ensure appropriate labelling of medicines at dispensing and to provide well-suited tools to identify MUIs in clinical settings to improve drug safety and patients' care in developing countries with limited capacities for drug analysis.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
healthcare
newly diagnosed
drug induced
chronic kidney disease
palliative care
physical activity
risk factors
patient reported